Instil Bio Inc banner
I

Instil Bio Inc
NASDAQ:TIL

Watchlist Manager
Instil Bio Inc
NASDAQ:TIL
Watchlist
Price: 8.9 USD 0.11%
Market Cap: $60.3m

During the last 3 months Instil Bio Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 26% over this period (open performance analysis).

The last transaction was made on Sep 10, 2025 by Laumas Sandeep , who sold 404.1k USD worth of TIL shares.

Last Transactions:
Laumas Sandeep
$-404.1k
Crouch Bronson
$+450k
Curative Ventures V Llc
$+450k
Vivo Capital Fund Ix, L.p.
$+300k
Shah Nimish P
$+104.6k
Nielsen Jack
$+300k
Mcgaughy R Kent Jr
$+450k
View All Transactions

During the last 3 months Instil Bio Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 26% over this period (open performance analysis).

The last transaction was made on Sep 10, 2025 by Laumas Sandeep , who sold 404.1k USD worth of TIL shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
404.1k USD
1
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Instil Bio Inc
Insider Trading Chart

Instil Bio Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Instil Bio Inc
Last Insider Transactions

Global
Insiders Monitor

Instil Bio Inc
Glance View

Market Cap
60.3m USD
Industry
Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company engages in developing cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company is headquartered in Dallas, Texas and currently employs 412 full-time employees. The company went IPO on 2021-03-19. The firm is focused on developing a cell therapy pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. TIL therapies leverage platform for TIL manufacturing has been designed for the scalability, logistics, and accessibility of TIL therapy. The company is advancing its lead TIL product candidate, ITIL-168, for the treatment of advanced melanoma. The company is also developing a class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR) platform. ITIL-168 is an autologous TIL therapy that it is initially developed for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma. Its pipeline also includes ITIL-306, its CoStAR-TIL product candidate.

TIL Intrinsic Value
0.04 USD
Overvaluation 100%
Intrinsic Value
Price $8.9
I

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett